Q4 2024 Holdings
Filed 2025-02-14 | 37 holdings | $1.5B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Apogee Therapeutics Inc(APGE) | COM | 03770N101 | $384.7M | 8,493,321 | 26.4% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $109.0M | 12,762,462 | 7.5% |
| Enliven Therapeutics Inc(ELVN) | COM | 29337E102 | $90.6M | 4,026,331 | 6.2% |
| Praxis Precision Medicines I(PRAX) | COM NEW | 74006W207 | $76.2M | 989,985 | 5.2% |
| Viridian Therapeutics Inc(VRDN) | COM | 92790C104 | $74.4M | 3,882,709 | 5.1% |
| Oruka Therapeutics Inc(ORKA) | COM | 687604108 | $63.7M | 3,285,620 | 4.4% |
| Spyre Therapeutics Inc(SYRE) | COM NEW | 00773J202 | $62.5M | 2,685,448 | 4.3% |
| Pharvaris N V(PHVS) | COM | N69605108 | $61.7M | 3,220,130 | 4.2% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $52.9M | 6,249,731 | 3.6% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $51.2M | 2,173,913 | 3.5% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $44.3M | 5,684,411 | 3.0% |
| Erasca Inc(ERAS) | COM | 29479A108 | $40.7M | 16,216,216 | 2.8% |
| Dianthus Therapeutics Inc(DNTH) | COM | 252828108 | $38.0M | 1,744,373 | 2.6% |
| Upstream BIO Inc(UPB) | COM | 91678A107 | $37.7M | 2,295,319 | 2.6% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $35.5M | 4,394,527 | 2.4% |
| Engene Holdings Inc(ENGN) | COM | 29286M105 | $33.6M | 5,046,414 | 2.3% |
| Merus N V | COM | N5749R100 | $24.9M | 592,411 | 1.7% |
| Astria Therapeutics Inc(CATBUSD) | COM | 04635X102 | $22.0M | 2,457,348 | 1.5% |
| Cidara Therapeutics Inc(CDTX) | COM NEW | 171757206 | $20.6M | 765,723 | 1.4% |
| Cullinan Therapeutics Inc(CGEM) | COM | 230031106 | $16.8M | 1,379,965 | 1.2% |
| 4D Molecular Therapeutics in(FDMT) | COM | 35104E100 | $16.4M | 2,952,371 | 1.1% |
| Artiva Biotherapeutics Inc(ARTV) | COM | 04317A107 | $16.2M | 1,609,569 | 1.1% |
| Mersana Therapeutics Inc | COM | 59045L106 | $14.7M | 10,257,790 | 1.0% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $9.9M | 1,345,780 | 0.7% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $9.4M | 2,629,786 | 0.6% |
| Applied Therapeutics Inc(APLT) | COM | 03828A101 | $8.6M | 9,990,591 | 0.6% |
| Perceptive Cap Solutions COR | CL A ORD SHS | G70077105 | $7.6M | 750,000 | 0.5% |
| Terns Pharmaceuticals Inc(TERN) | COM | 880881107 | $6.0M | 1,077,090 | 0.4% |
| Taysha Gene Therapies Inc(TSHA) | COM SHS | 877619106 | $5.6M | 3,225,180 | 0.4% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $5.2M | 1,266,457 | 0.4% |
| Zura BIO LTD(ZURA) | CLASS A ORD SHS | G9TY5A101 | $5.1M | 2,023,166 | 0.3% |
| Century Therapeutics Inc(IPSC) | COM | 15673T100 | $4.0M | 3,957,186 | 0.3% |
| Casi Pharmaceuticals Inc(CASIF) | ORD SHS | G1933S101 | $2.8M | 987,259 | 0.2% |
| Tenaya Therapeutics Inc(TNYA) | COM | 87990A106 | $2.2M | 1,555,556 | 0.2% |
| Tenax Therapeutics Inc(TENX) | COM NEW | 88032L605 | $1.3M | 208,333 | 0.1% |
| Glycomimetics Inc(GLYCEUR) | COM | 38000Q102 | $747.0K | 3,000,000 | 0.1% |
| Instil BIO Inc(TIL) | COM NEW | 45783C200 | $633.3K | 33,177 | 0.0% |